| Patients | |||
---|---|---|---|---|
All n = 244 | Compensated n = 101 | Decompensated n = 143 | ||
Age# | 56 (49–65) | 54 (49–64) | 57 (51–65) | |
Sex (m/f) | 124/120 | 47/54 | 77/66 | |
Alcoholic etiology* | 137 (56.1%) | 36 (35.6%) | 101 (70.6%) | |
Child- | A | 153 (62.7%) | 97 (96.0%) | 56 (39.2%) |
Pugh | B | 80 (32.8%) | 4 (4.0%) | 76 (53.1%) |
Stage* | C | 11 (4.5%) | 0 (0.0%) | 11 (7.7%) |
MELD score# | 11 (8–14) | 9 (7–12) | 12 (9–14) | |
Bilirubin (μmol/L)# | 26 (15–42) | 18 (13–30) | 30 (19–51) | |
Albumin (g/L)# | 38 (33–42) | 42 (37–45) | 36 (31–40) | |
Creatinine (μmol/L)# | 67 (54–83.5) | 62 (52–76) | 70 (55–88) | |
INR# | 1.17 (1.09–1.31) | 1.11 (1.05–1.21) | 1.22 (1.12–1.36) | |
WBC (103/ml) | 5.26 (4.19–7.14) | 5.55 (4.25–7.85) | 5.24 (4.05–6.89) | |
CRP (mg/L)# | 3.84 (1.19–7.94) | 1.41 (0.50–3.95) | 5.67 (2.58–9.87) | |
Anemia*o | 98 (40.2%) | 23 (22.8%) | 75 (52.4%) | |
Previous VB* | 59 (24.2%) | 0 (0.0%) | 59 (41.3%) | |
Ascites* | 88 (36.1%) | 0 (0.0%) | 88 (61.5%) | |
Comorbidity* | 127 (52%) | 47 (46.5%) | 80 (55.9%) | |
HCC* | 26 (10.7%) | 12 (11.9%) | 14 (9.8%) | |
Ferritin (μg/L)# | 121.2 (39.7–310.8) | 133.7 (49.2–370.1) | 103.4 (35.8–271.9) | |
Ferritin (L/M/H) | 61/122/61 | 22/48/31 | 39/74/30 |